List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 53 studies with search of: "2,4-thiazolidinedione"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Active, not recruiting A Study to Compare the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly to Those of Sitagliptin and a Thiazolidinedione in Subjects With Type 2 Diabetes Treated With Metformin (DURATION - 2)
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: exenatide once weekly;   Drug: sitagliptin;   Drug: thiazolidinedione;   Drug: placebo tablet;   Drug: placebo once weekly
2 Active, not recruiting Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using a Thiazolidinedione or a Thiazolidinedione and Metformin
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: exenatide;   Drug: placebo
3 Active, not recruiting Safety of Exenatide Once Weekly in Patients With Type 2 Diabetes Mellitus Treated With Thiazolidinedione Alone or Thiazolidinedione in Combination With Metformin
Condition: Type 2 Diabetes
Intervention: Drug: exenatide
4 Completed Safety and Efficacy of Vildagliptin vs. Thiazolidinedione as Add-on Therapy to Metformin in Patients With Type 2 Diabetes Not Controlled With Metformin Alone
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: vildagliptin;   Drug: thiazolidinedione (TZD)
5 Not yet recruiting Thiazolidinedione Intervention With Vitamin D Evaluation
Conditions: Cardiovascular Disease;   Type 2 Diabetes Mellitus
Interventions: Drug: pioglitazone;   Drug: placebo;   Dietary Supplement: vitamin D;   Dietary Supplement: placebo;   Drug: rosiglitazone
6 Recruiting Islet Transplantation in Type 1 Diabetic Patients
Condition: Type 1 Diabetes
Intervention: Drug: Thiazolidinedione
7 Completed Determine Whether Glycemic Control is Different Between Lantus & a 3rd Oral Agent When Failure With Other Treatment
Condition: Diabetes Mellitus
Interventions: Drug: Lantus (insulin glargine [rDNA origin] injection);   Drug: Metformin;   Drug: Glyburide;   Drug: Thiazolidinedione
8 Recruiting Ghrelin Regulation and Structure: Effect of Thiazolidinedione Therapy on Ghrelin
Conditions: Obesity;   Insulin Resistance
Interventions: Drug: placebo;   Drug: pioglitazone
9 Completed Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using Thiazolidinediones or Thiazolidinediones and Metformin
Condition: Type 2 Diabetes Mellitus
Intervention: Drug: exenatide
10 Not yet recruiting Comparison of the Effect of Exenatide Versus Sitagliptin on 24-Hour Average Glucose in Patients With Type 2 Diabetes on Metformin or a Thiazolidinedione
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: exenatide;   Drug: sitagliptin;   Drug: placebo;   Drug: placebo
11 Completed Effect of Thiazolidinedione Treatment Vascular Risk Markers
Conditions: Diabetes Mellitus, Type 2;   Vascular Diseases
Interventions: Drug: Rosiglitazone;   Drug: Pioglitazone
12 Terminated A Retrospective Study of the Role of Thiazolidinediones to Reduce the Incidence of Atrial Arrhythmias
Condition: Atrial Fibrillation
Intervention: Procedure: TZD reducing the incidence of atrial arrhythmias
13 Recruiting Integrating the Genetic and Metabolic Faces of Obesity
Conditions: Insulin Resistance;   Obesity;   Metabolic Syndrome
Interventions: Behavioral: weight loss;   Drug: thiazolidinedione
14 Recruiting Safety and Efficacy of Exenatide Once Weekly Injection Versus Metformin, Dipeptidyl Peptidase-4 Inhibitor, or Thiazolidinedione as Monotherapy in Drug-Naive Patients With Type 2 Diabetes (DURATION-4)
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: exenatide once weekly;   Drug: metformin;   Drug: sitagliptin;   Drug: pioglitazone
15 Recruiting Add-on to Thiazolidinedione (TZD) Failures
Condition: Type 2 Diabetes
Interventions: Drug: Dapagliflozin;   Drug: Dapagliflozin;   Drug: Placebo
16 Active, not recruiting Bypass Angioplasty Revascularization Investigation in Type 2 Diabetes
Conditions: Coronary Disease;   Cardiovascular Diseases;   Heart Diseases;   Insulin Resistance;   Diabetes Mellitus;   Diabetes Mellitus, Non-Insulin-Dependent
Interventions: Procedure: Angioplasty, Transluminal, Percutaneous Coronary, other catheter-based interventions;   Procedure: Coronary Artery Bypass;   Drug: Biguanides, thiazolidinediones;   Drug: Insulin, sulfonylurea;   Drug: ACE Inhibitors, Angiotensin Receptor Blockers, Beta Blockers, Calcium Channel Blockers
17 Completed Gene Regulation by Thiazolidinediones
Condition: Inflammatory Bowel Disease
Intervention: Drug: Rosiglitazone
18 Recruiting Thiazolidinediones (TZD) Bone Loss and the Effects on Bone Marrow Differentiation and Osteoblast Formation
Condition: Osteoporosis
Intervention: Procedure: Stromal Cells Sample
19 Active, not recruiting Metabolic Effects of Thiazolidinediones in Chronic Kidney Disease
Condition: Chronic Kidney Disease
Interventions: Drug: pioglitazone;   Drug: placebo
20 Recruiting Dietary Fatty Acids as Complementary Therapy for Thiazolidinediones in Type 2 Diabetes Mellitus
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: rosiglitazone;   Dietary Supplement: conjugated linoleic acid (CLA);   Dietary Supplement: conjugated linoleic acid (CLA)

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services